Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.34 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.33 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4603384 | 0.98 | CYP2C19 (0.42) | CYP2C19CNR2ALDH1A1TSHRKDM4E | |
| SCHEMBL146243 | 0.92 | CYP2C19 (0.44) | CYP2C19CNR2ALDH1A1TSHRKDM4E | |
| SCHEMBL25913652 | 0.91 | CNR2 (0.44) | CYP2C19CNR2ALDH1A1TSHRKDM4E | |
| SCHEMBL33921 | 0.83 | CYP2C19 (0.47) | CYP2C19CNR2ALDH1A1TSHRKDM4E | |
| SCHEMBL15714440 | 0.82 | CNR2 (0.43) | CYP2C19CNR2ALDH1A1TSHRKDM4E | |
| SCHEMBL22321048 | 0.82 | CNR2 (0.51) | CYP2C19CNR2ALDH1A1TSHRRAB9A | |
| SCHEMBL22321046 | 0.82 | CNR2 (0.51) | CYP2C19CNR2ALDH1A1TSHRRAB9A | |
| SCHEMBL22321042 | 0.82 | CNR2 (0.51) | CYP2C19CNR2ALDH1A1TSHRRAB9A | |
| SCHEMBL22321039 | 0.82 | CNR2 (0.51) | CYP2C19CNR2ALDH1A1TSHRRAB9A | |
| SCHEMBL22321099 | 0.82 | CNR2 (0.51) | CYP2C19CNR2ALDH1A1TSHRRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2390273-B1 | DUAL-CURE CURABLE MATERIAL KIT | TOKUYAMA DENTAL CORP (JP) | 2015-11-04 | — | — | EP | disclosed |
| US-8993652-B2 | Dual-cure curable material kit | TOKUYAMA DENTAL CORPORATION (JP) | 2015-03-31 | — | — | US | disclosed |
| US-20120059079-A1 | DUAL-CURE CURABLE MATERIAL KIT | TOKUYAMA DENTAL CORPORATION (JP) | 2012-03-08 | — | — | US | disclosed |
| EP-2390273-A1 | DUAL-CURE CURABLE MATERIAL KIT | Tokuyama Dental Corporation (JP) | 2011-11-30 | — | — | EP | disclosed |
| US-20110255272-A1 | Simulated candle apparatus | PRIVAS YVES | 2011-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059079-A1 | DUAL-CURE CURABLE MATERIAL KIT | KIT, DSTYK, H1-5 | CYP2C19 2693/4885CNR2 3376/4885ALDH1A1 921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.